INTRODUCTION: @entity1 undergoing catheter ablation for @entity1165 ( @entity1165 ) may require epicardial mapping. In @entity1 with end-stage @entity712 , hybrid surgical epicardial mapping and ablation during the period of left ventricular assist device (LVAD) implantation may be considered in select @entity1 to reduce post-LVAD @entity1165 . METHODS AND RESULTS: From March 2009 to October 2012, 5 @entity1 (4 @entity1 and 1 @entity1 , age range 52-73 years) underwent open chest electrophysiology study and epicardial mapping for recurrent @entity1165 while the heart was exposed during the period of LVAD implantation. Epicardial mapping was considered if @entity1 had recurrent @entity1165 despite failed prior endocardial ablation and/or electrocardiogram (EKG) features of an epicardial exit. Activation and/or a substrate mapping approach were employed during all procedures. Three of 5 @entity1 (60%) had acute procedural success. In all @entity1 , @entity1165 was either eliminated or significantly reduced with epicardial ablation. One @entity1 had mediastinal bleeding delaying sternal closure. During a follow-up period of 363    368 days, 4 @entity1 died due to nonarrhythmic causes. CONCLUSIONS: Open-chest hybrid epicardial mapping and ablation for recurrent @entity1165 is feasible and can be considered in select @entity1 during the period of LVAD implantation.

Safety and Feasibility of Open Chest Epicardial Mapping and Ablation of XXXX During the Period of Left Ventricular Assist Device Implantation.

@entity1 :: ('9606', 'Species') :: ['Patients', 'woman', 'patients', 'patient', 'men'] @entity712 :: ('MESH:D006333', 'Disease') :: ['heart failure'] @entity1165 :: ('MESH:D017180', 'Disease') :: ['VT', 'ventricular tachycardia']
@entity1165 :: (MESH:D017180,Disease) :: ['Ventricular Tachycardia']
